Peter Huang

Peter Huang

Company: Zentalis Pharmaceuticals

Job title: Senior Vice President Discovery

Seminars:

Discovery & Progress of ZN-c3, a Highly Potent & Selective WEE1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer 11:30 am

Discovery of ZN-c3 as a potent and selective Wee1 inhibitor Exploring ZN-c3 antitumor effect as a single agent and in combination Diving into recent ZN-c3 clinical dataRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.